Literature DB >> 33571172

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2021.

A Patricia Wodi, Kevin Ault, Paul Hunter, Veronica McNally, Peter G Szilagyi, Henry Bernstein.   

Abstract

At its October 2020 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the 2021 Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger. After Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration (FDA), ACIP issued an interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years at its December 12, 2020, meeting (1). In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent immunization schedule. After Emergency Use Authorization of Moderna COVID-19 vaccine by FDA, ACIP issued an interim recommendation for use of Moderna COVID-19 vaccine in persons aged ≥18 years at its December 19, 2020, emergency meeting (2).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33571172      PMCID: PMC7877586          DOI: 10.15585/mmwr.mm7006a1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

1.  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

Authors:  Sarah A Mbaeyi; Catherine H Bozio; Jonathan Duffy; Lorry G Rubin; Susan Hariri; David S Stephens; Jessica R MacNeil
Journal:  MMWR Recomm Rep       Date:  2020-09-25

2.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-12-18       Impact factor: 17.586

3.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-01       Impact factor: 35.301

  4 in total
  5 in total

Review 1.  Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies.

Authors:  Lanying Du; Yang Yang; Xiujuan Zhang; Fang Li
Journal:  Nanoscale       Date:  2022-01-27       Impact factor: 7.790

2.  Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness.

Authors:  Ousseny Zerbo; Bruce Fireman; Nicola P Klein
Journal:  Expert Rev Vaccines       Date:  2021-10-08       Impact factor: 5.683

3.  Inadequate Vaccine Responses in Children With Multiple Sclerosis.

Authors:  Jonathan D Santoro; Laura E Saucier; Runi Tanna; Sarah E Wiegand; Dania Pagarkar; Adam F Tempchin; Mellad Khoshnood; Nusrat Ahsan; Keith Van Haren
Journal:  Front Pediatr       Date:  2021-12-01       Impact factor: 3.418

4.  The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination.

Authors:  Igor Rudan; Davies Adeloye; Vittal Katikireddi; Josie Murray; Colin Simpson; Syed Ahmar Shah; Chris Robertson; Aziz Sheikh
Journal:  J Glob Health       Date:  2021-12-25       Impact factor: 7.664

5.  Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China.

Authors:  Mengdi Ji; Zhuoying Huang; Jia Ren; Abram L Wagner
Journal:  Hum Vaccin Immunother       Date:  2022-03-23       Impact factor: 4.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.